Business Context and Reporting Period
Company: IRADIMED CORP (IRMD)
Filing Type: Form 8-K (Current Report)
Date of Report: July 30, 2020
Reporting Period: Second quarter ended June 30, 2020
Context: This filing serves to announce the issuance of a press release containing financial results for the second quarter of 2020. The detailed financial data is contained in Exhibit 99.1 (Press Release) and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text is a cover document for the Form 8-K and does not contain specific numerical data. The filing explicitly references a press release (Exhibit 99.1) for the actual figures. Therefore, the following metrics are not available in the source text:
- Revenue: Not provided in text.
- Profit: Not provided in text.
- Cash Flow: Not provided in text.
- Margins: Not provided in text.
- Debt and Liquidity: Not provided in text.
Material Changes
The filing text does not provide specific comparative data or material changes versus the prior period. It only confirms the announcement of Q2 2020 results.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release regarding Q2 2020 results but does not include the content of that commentary.
Guidance and Outlook: No forward-looking guidance is present in the provided text.
Risks and Contingencies: No specific risks or contingencies are detailed in this cover document.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 30, 2020) for actual revenue, net income, and cash flow figures.
- Verify the specific impact of the COVID-19 pandemic on operations, as this is a common material factor for Q2 2020 filings (though not explicitly detailed in this text).
- Confirm the company's liquidity position and debt covenants in the full press release or subsequent 10-Q filing.
- Note that the information in Item 2.02 is not deemed "filed" under Section 18 of the Exchange Act, limiting liability protections for the data contained in the press release.